The FDA approves Aduhelm (aducanumab) to treat patients with Alzheimer’s disease
FDA approves Aduhelm (aducanumab) using the accelerated approval pathway used for drugs treating serious or life-threatening illness that provide a meaningful therapeutic advantage over existing treatments. The drug is shown […]